Der blev gennemført en hovedundersøgelse af Abraxanes virkning hos 460 kvinder med metastatisk brystkræft, hvoraf tre fjerdedele tidligere var blevet behandlet med en antracyklin.
The effectiveness of Abraxane has been studied in one main study involving 460 women with metastatic breast cancer, around three-quarters of whom had received an anthracycline in the past.